Do you have swine flu. Register your concern. Since World Health Organization has stopped the counting we will try to do our own, but we need your help.
Readers have reported, chesty cough, runny nose, ear aches, headaches, body pain, tempature.
Please let us know what you are like. We like to know.
I got Swine Flue? Not Sure,
This is a diary of how it effected me and what I took for it.
1st day - Dry chesty cough - I took cough medicine, and 2/500 paracitamole
2nd day - High fever, followed by shivering and swetting, Whole body pain - I emptied the medicine cabinet, vitamin c, paracitamole, cough medicine, muti vitamin, hot soop, and sleep
3rd day - Running nose and sneezing, cough medicine. Mid Day fever is back.Visiting the toilet frequently, not a good idea to leave the house.
4th day we wait and see - I dought it being Swine Flu.
Please let us know if you have had Swine Flu.
News Clips
Thank you for your feed backs on this web site. Your assistance is appriciated. Please tell your freinds and familly, the more people know about this site the more feed back we will accumulate.
Latest phone numbers from athorities in the UK
16 July 2009 last from World Health Organization
1st June 2009 seven days apart. Increase of 50%, increase of 15 new countries
21st May 2009 increase of 30% over 4 days. Is it ever going to go down.
Statement by WHO Director-General, Dr Margaret Chan
29 April 2009
Sky 29/04/09 3:31pm
SKY 29/04/09 10:33am
The National Pandemic Flu Service has been launched in England.
If you are in England and feel like you may have swine flu, visit the new website by following the link below, or call 0800 1 513 100 (Textphone - 0800 1 513 200).
People who have swine flu symptoms will be given a unique access number and told where their nearest antiviral collection point is. They should then ask a flu friend - a friend or relative who doesn't have swine flu - to go and pick up their antivirals. The flu friend must show their own ID as well as that of the patient.
Pandemic (H1N1) 2009 briefing note 3
Changes in reporting requirements for pandemic (H1N1) 2009 virus infection
16 JULY 2009 | GENEVA -- As the 2009 pandemic evolves, the data needed for risk assessment, both within affected countries and at the global level, are also changing.
At this point, further spread of the pandemic, within affected countries and to new countries, is considered inevitable.
This assumption is fully backed by experience. The 2009 influenza pandemic has spread internationally with unprecedented speed. In past pandemics, influenza viruses have needed more than six months to spread as widely as the new H1N1 virus has spread in less than six weeks.
The increasing number of cases in many countries with sustained community transmission is making it extremely difficult, if not impossible, for countries to try and confirm them through laboratory testing. Moreover, the counting of individual cases is now no longer essential in such countries for monitoring either the level or nature of the risk posed by the pandemic virus or to guide implementation of the most appropriate response measures.
Monitoring still needed
This pandemic has been characterized, to date, by the mildness of symptoms in the overwhelming majority of patients, who usually recover, even without medical treatment, within a week of the onset of symptoms. However, there is still an ongoing need in all countries to closely monitor unusual events, such as clusters of cases of severe or fatal pandemic (H1N1) 2009 virus infection, clusters of respiratory illness requiring hospitalization, or unexplained or unusual clinical patterns associated with serious or fatal cases.
Other potential signals of change in the currently prevailing pattern include unexpected, unusual or notable changes in patterns of transmission. Signals to be vigilant for include spikes in rates of absenteeism from schools or workplaces, or a more severe disease pattern, as suggested by, for example, a surge in emergency department visits.
In general, indications that health services are having difficulty coping with cases mean that such systems are under stress but they may also be a signal of increasing cases or a more severe clinical picture.
A strategy that concentrates on the detection, laboratory confirmation and investigation of all cases, including those with mild illness, is extremely resource-intensive. In some countries, this strategy is absorbing most national laboratory and response capacity, leaving little capacity for the monitoring and investigation of severe cases and other exceptional events.
Regular updates on newly affected countries
For all of these reasons, WHO will no longer issue the global tables showing the numbers of confirmed cases for all countries. However, as part of continued efforts to document the global spread of the H1N1 pandemic, regular updates will be provided describing the situation in the newly affected countries. WHO will continue to request that these countries report the first confirmed cases and, as far as feasible, provide weekly aggregated case numbers and descriptive epidemiology of the early cases.
For countries already experiencing community-wide transmission, the focus of surveillance activities will shift to reporting against the established indicators for the monitoring of seasonal influenza activity. Those countries are no longer required to submit regular reports of individual laboratory-confirmed cases to WHO.
Monitoring the virological characteristics of the pandemic virus will be important throughout the pandemic and some countries have well-established laboratory-based surveillance systems in place already for seasonal influenza virus monitoring. Even in countries with limited laboratory capacity, WHO recommends that the initial virological assessment is followed by the testing of at least 10 samples per week in order to confirm that disease activity is due to the pandemic virus and to monitor changes in the virus that may be important for case management and vaccine development.
Updated WHO guidelines for global surveillance reflect in greater detail these recommended changes, in line with reporting requirements set out in the International Health Regulations.
Pandemic (H1N1) 2009 briefing note 2
WHO recommendations on pandemic (H1N1) 2009 vaccines
13 JULY 2009 | GENEVA -- On 7 July 2009, the Strategic Advisory Group of Experts (SAGE) on Immunization held an extraordinary meeting in Geneva to discuss issues and make recommendations related to vaccine for the pandemic (H1N1) 2009.
SAGE reviewed the current pandemic situation, the current status of seasonal vaccine production and potential A(H1N1) vaccine production capacity, and considered potential options for vaccine use.
The experts identified three different objectives that countries could adopt as part of their pandemic vaccination strategy:
- protect the integrity of the health-care system and the country's critical infrastructure;
- reduce morbidity and mortality; and
- reduce transmission of the pandemic virus within communities.
Countries could use a variety of vaccine deployment strategies to reach these objectives but any strategy should reflect the country’s epidemiological situation, resources and ability to access vaccine, to implement vaccination campaigns in the targeted groups, and to use other non-vaccine mitigation measures.
Although the severity of the pandemic is currently considered to be moderate with most patients experiencing uncomplicated, self-limited illness, some groups such as pregnant women and persons with asthma and other chronic conditions such as morbid obesity appear to be at increased risk for severe disease and death from infection.
Since the spread of the pandemic virus is considered unstoppable, vaccine will be needed in all countries. SAGE emphasized the importance of striving to achieve equity among countries to access vaccines developed in response to the pandemic (H1N1) 2009
The following recommendations were provided to the WHO Director-General:
- All countries should immunize their health-care workers as a first priority to protect the essential health infrastructure. As vaccines available initially will not be sufficient, a step-wise approach to vaccinate particular groups may be considered. SAGE suggested the following groups for consideration, noting that countries need to determine their order of priority based on country-specific conditions: pregnant women; those aged above 6 months with one of several chronic medical conditions; healthy young adults of 15 to 49 years of age; healthy children; healthy adults of 50 to 64 years of age; and healthy adults of 65 years of age and above.
- Since new technologies are involved in the production of some pandemic vaccines, which have not yet been extensively evaluated for their safety in certain population groups, it is very important to implement post-marketing surveillance of the highest possible quality. In addition, rapid sharing of the results of immunogenicity and post-marketing safety and effectiveness studies among the international community will be essential for allowing countries to make necessary adjustments to their vaccination policies.
- In view of the anticipated limited vaccine availability at global level and the potential need to protect against "drifted" strains of virus, SAGE recommended that promoting production and use of vaccines such as those that are formulated with oil-in-water adjuvants and live attenuated influenza vaccines was important.
- As most of the production of the seasonal vaccine for the 2009-2010 influenza season in the northern hemisphere is almost complete and is therefore unlikely to affect production of pandemic vaccine, SAGE did not consider that there was a need to recommend a "switch" from seasonal to pandemic vaccine production.
WHO Director-General Dr Margaret Chan endorsed the above recommendations on 11 July 2009, recognizing that they were well adapted to the current pandemic situation. She also noted that the recommendations will need to be changed if and when new evidence become available.
SAGE was established by the WHO Director-General in 1999 as the principal advisory group to WHO for vaccines and immunization. It comprises 15 members who serve in their personal capacity and represent a broad range of disciplines from around the world in the fields such as epidemiology, public health, vaccinology, paediatrics, internal medicine, infectious diseases, immunology, drug regulation, programme management, immunization delivery, and health-care administration.
Additional participants in the SAGE meeting included members of the ad hoc policy advisory working group on influenza A(H1N1) vaccine, chairs of the regional technical advisory groups and external experts. Observers included industry representatives and regulators who did not take part in the recommendation process in order to avoid conflicts of interest.
105 of countries infected. To include 55,867 cases of which 11,580 are new cases from last report, and number of fatalities has increased by 58 to 238
24th June 2009 - 105 of countries infected. To include 55,867 cases of which 11,580 are new cases from last report, and number of fatalities has increased by 58 to 238
19th June 2009 - 74 of countries infected. To include 44,287 cases of which 4667 are new cases from last report, and number of fatalities has increased by 13 to 180
12 June 2009 -- As of 07:00 GMT, 12 June 2009, 74 countries have officially reported 29,669 cases of influenza A(H1N1) infection, including 145 deaths.
The breakdown of the number of laboratory-confirmed cases by country is given in the following table and map.
Map of the spread of Influenza A(H1N1): number of laboratory confirmed cases and deaths [jpg 203kb]![Map of the spread of Influenza A(H1N1): number of laboratory confirmed cases and deaths [jpg 203kb]](images/11june2009.jpg){kind=link}
Influenza A(H1N1) - update 42
1 June 2009 -- As of 06:00 GMT, 1 June 2009, 62 countries have officially reported 17 410 cases of influenza A(H1N1) infection, including 115 deaths.
The breakdown of the number of laboratory-confirmed cases by country is given in the following table and map.
Map of the spread of Influenza A(H1N1): number of laboratory confirmed cases and deaths [jpg 995kb]![Map of the spread of Influenza A(H1N1): number of laboratory confirmed cases and deaths [jpg 995kb]](http://www.swinepandemic.co.uk/images/H1N1map20090601.jpg){kind=link}
Influenza A(H1N1) - update 35
21 May 2009 -- As of 06:00 GMT, 21 May 2009, 41 countries have officially reported 11 034 cases of influenza A(H1N1) infection, including 85 deaths.
The breakdown of the number of laboratory-confirmed cases by country is given in the following table and map.
17 May 2009 -- As of 06:00 GMT, 17 May 2009, 39 countries have officially reported 8480 cases of influenza A(H1N1) infection.
Mexico has reported 2895 laboratory confirmed human cases of infection, including 66 deaths. The United States has reported 4714 laboratory confirmed human cases, including four deaths. Canada has reported 496 laboratory confirmed human cases, including one death. Costa Rica has reported nine laboratory confirmed human cases, including one death.
The following countries have reported laboratory confirmed cases with no deaths - Argentina (1), Australia (1), Austria (1), Belgium (4), Brazil (8), China (5), Colombia (11), Cuba (3), Denmark (1), Ecuador (1), El Salvador (4), Finland (2), France (14), Germany (14), Guatemala (3), India (1), Ireland (1), Israel (7), Italy (9), Japan (7), Malaysia (2), Netherlands (3), New Zealand (9), Norway (2), Panama (54), Peru (1), Poland (1), Portugal (1), Republic of Korea (3), Spain (103), Sweden (3), Switzerland (1), Thailand (2), Turkey (1), and the United Kingdom (82).
14 May 2009 -- As of 06:00 GMT, 14 May 2009, 33 countries have officially reported 6497 cases of influenza A(H1N1) infection.
Mexico has reported 2446 laboratory confirmed human cases of infection, including 60 deaths. The United States has reported 3352 laboratory confirmed human cases, including three deaths. Canada has reported 389 laboratory confirmed human cases, including one death. Costa Rica has reported eight laboratory confirmed human cases, including one death.
WHO is not recommending travel restrictions related to the outbreak of the influenza A(H1N1) virus.
Individuals who are ill should delay travel plans and returning travelers who fall ill should seek appropriate medical care. These recommendations are prudent measures which can limit the spread of many communicable diseases, including influenza.
Influenza A(H1N1) - update 26
12 May 2009 -- As of 06:00 GMT, 12 May 2009, 30 countries have officially reported 5251 cases of influenza A(H1N1) infection.
Mexico has reported 2059 laboratory confirmed human cases of infection, including 56 deaths. The United States has reported 2600 laboratory confirmed human cases, including three deaths. Canada has reported 330 laboratory confirmed human cases, including one death. Costa Rica has reported eight laboratory confirmed human cases, including one death.
The following countries have reported laboratory confirmed cases with no deaths - Argentina (1), Australia (1), Austria (1), Brazil (8), China (2, comprising 1 in China, Hong Kong Special Administrative Region, and 1 in mainland China), Colombia (3), Denmark (1), El Salvador (4), France (13), Germany (12), Guatemala (1), Ireland (1), Israel (7), Italy (9), Japan (4), Netherlands (3), New Zealand (7), Norway (2), Panama (16), Poland (1), Portugal (1), Republic of Korea (3), Spain (95), Sweden (2), Switzerland (1) and the United Kingdom (55).
WHO is not recommending travel restrictions related to the outbreak of the influenza A(H1N1) virus.
Individuals who are ill should delay travel plans and returning travelers who fall ill should seek appropriate medical care. These recommendations are prudent measures which can limit the spread of many communicable diseases,
11 May 2009 -- The major determinant of the severity of an influenza pandemic is the inherent virulence of the virus. But many other factors influence the overall severity of a pandemic’s impact.
10 May 2009 -- As of 07:30 GMT, 10 May 2009, 29 countries have officially reported 4379 cases of influenza A(H1N1) infection.
Mexico has reported 1626 laboratory confirmed human cases of infection, including 45 deaths. The United States has reported 2254 laboratory confirmed human cases, including two deaths. Canada has reported 280 laboratory confirmed human cases, including one death. Costa Rica has reported eight laboratory confirmed human cases, including one death.
The following countries have reported laboratory confirmed cases with no deaths - Argentina (1), Australia (1), Austria (1), Brazil (6), China, Hong Kong Special Administrative Region (1), Colombia (1), Denmark (1), El Salvador (2), France (12), Germany (11), Guatemala (1), Ireland (1), Israel (7), Italy (9), Japan (4), Netherlands (3), New Zealand (7), Panama (3), Poland (1), Portugal (1), Republic of Korea (3), Spain (93), Sweden (1), Switzerland (1) and the United Kingdom (47).
Seven people who were in contact with the two infected individuals in Scotland are being "appropriately cared for," after showing "mild" symptoms which have not been confirmed as swine flu. They are receiving drugs at home, not in hospital.
The HPA has advised people to follow general infection control practices and good hygiene to reduce transmission of all viruses.
This includes covering their nose and mouth when coughing or sneezing, disposing of dirty tissues promptly and carefully, washing hands frequently with soap and water and cleaning surfaces which are regularly touched.
But it is not enough. The number of the ill has raised to 39 by 10th May.
8 May 2009 -- As of 06:00 GMT, 8 May 2009, 24 countries have officially reported 2384 cases of influenza A (H1N1) infection.
Mexico has reported 1112 laboratory confirmed human cases of infection, including 42 deaths. The United States has reported 896 laboratory confirmed human cases, including two deaths.
7 May 2009 -- As of 06:00 GMT, 7 May 2009, 23 countries have officially reported 2099 cases of influenza A(H1N1) infection.
Mexico has reported 1112 laboratory confirmed human cases of infection, including 42 deaths. The United States has reported 642 laboratory confirmed human cases, including two deaths.
The following countries have reported laboratory confirmed cases with no deaths - Austria (1), Canada (201), China, Hong Kong Special Administrative Region (1), Colombia (1), Costa Rica (1), Denmark (1), El Salvador (2), France (5), Germany (9), Guatemala (1), Ireland (1), Israel (4), Italy (5), Netherlands (1), New Zealand (5), Portugal (1), Republic of Korea (2), Spain (73), Sweden (1), Switzerland (1) and the United Kingdom (28).
WHO is not recommending travel restrictions related to the outbreak of the influenza A(H1N1) virus.
Individuals who are ill should delay travel plans and returning travelers who fall ill should seek appropriate medical care. These recommendations are prudent measures which can limit the spread of many communicable diseases, including influenza.
Further information on the situation will be available on the WHO website on a regular basis.
It is considered prudent for people who are ill to delay international travel and for people developing symptoms following international travel to seek medical attention, in line with guidance from national authorities. Individuals are advised to wash hands thoroughly with soap and water on a regular basis and should seek medical attention if they develop any symptoms of influenza-like illness.
WHO advises no restriction of regular travel or closure of borders.
There is no risk of infection from this virus from consumption of well-cooked pork and pork products.
Further information on the situation will be available on the WHO website on a regular basis.
5 May 2009 -- As of 16:00 GMT, 5 May 2009, 21 countries have officially reported 1490 cases of influenza A (H1N1) infection.
Mexico has reported 822 laboratory confirmed human cases of infection, including 29 deaths. The United States has reported 403 laboratory confirmed human cases, including two deaths.
The following countries have reported laboratory confirmed cases with no deaths - Austria (1), Canada (140), China, Hong Kong Special Administrative Region (1), Colombia (1), Costa Rica (1), Denmark (1), El Salvador (2), France (4), Germany (9), Ireland (1), Israel (4), Italy (5), Netherlands (1), New Zealand (6), Portugal (1), Republic of Korea (2), Spain (57), Switzerland (1) and the United Kingdom (27).
4 May 2009 -- As of 18:00 GMT, 4 May 2009, 21 countries have officially reported 1085 cases of influenza A (H1N1) infection.
Mexico has reported 590 laboratory confirmed human cases of infection, including 25 deaths. The United States has reported 286 laboratory confirmed human cases, including one death.
The following countries have reported laboratory confirmed cases with no deaths - Austria (1), Canada (101), China, Hong Kong Special Administrative Region (1), Costa Rica (1), Colombia (1), Denmark (1), El Salvador (2), France (4), Germany (8), Ireland (1), Israel (4), Italy (2), Netherlands (1), New Zealand (6), Portugal (1), Republic of Korea (1), Spain (54), Switzerland (1) and the United Kingdom (18).
1 May 2009 -- The situation continues to evolve rapidly. As of 06:00 GMT, 1 May 2009, 11 countries have officially reported 331 cases of influenza A(H1N1) infection.
The United States Government has reported 109 laboratory confirmed human cases, including one death. Mexico has reported 156 confirmed human cases of infection, including nine deaths.
There are now five cases of swine flu confirmed in the UK - while the first results on 23 people who came into contact with an infected couple are negative.
The swine flu epidemic has claimed its first victim in the United States - a 23-month-old child who died in Texas.
Leaflets about the swine flu outbreak and how to prevent its spread are to be delivered to every UK household.
Concern that the world could be on the brink of the first influenza pandemic in more than 40 years escalated Sunday 26th April as France, Hong Kong, New Zealand and Spain reported potential new cases in which people had been infected with swine flu and Canada confirmed several new cases. In the U.S., where 20 such infections have been confirmed, federal health officials declared a public-health emergency and are preparing to distribute to state and local agenciesa quarter of the country's 50 million-dose stockpile of antiviral drugs. Meanwhile, in hard-hit Mexico, where more than 80 people have died from what is believed to be swine flu, the government closed all public schools and canceled hundreds of public events in Mexico City.
Influenza A(H1N1)
Ladies and gentlemen,
Based on assessment of all available information, and following several expert consultations, I have decided to raise the current level of influenza pandemic alert from phase 4 to phase 5.
Influenza pandemics must be taken seriously precisely because of their capacity to spread rapidly to every country in the world.
Related links Watch the video [wmv, 7min 13 sec] |
On the positive side, the world is better prepared for an influenza pandemic than at any time in history.
Preparedness measures undertaken because of the threat from H5N1 avian influenza were an investment, and we are now benefitting from this investment.
For the first time in history, we can track the evolution of a pandemic in real-time.
I thank countries who are making the results of their investigations publicly available. This helps us understand the disease.
I am impressed by the work being done by affected countries as they deal with the current outbreaks.
I also want to thank the governments of the USA and Canada for their support to WHO, and to Mexico.
Let me remind you. New diseases are, by definition, poorly understood. Influenza viruses are notorious for their rapid mutation and unpredictable behaviour.
WHO and health authorities in affected countries will not have all the answers immediately, but we will get them.
WHO will be tracking the pandemic at the epidemiological, clinical, and virological levels.
The results of these ongoing assessments will be issued as public health advice, and made publicly available.
All countries should immediately activate their pandemic preparedness plans. Countries should remain on high alert for unusual outbreaks of influenza-like illness and severe pneumonia.
At this stage, effective and essential measures include heightened surveillance, early detection and treatment of cases, and infection control in all health facilities.
This change to a higher phase of alert is a signal to governments, to ministries of health and other ministries, to the pharmaceutical industry and the business community that certain actions should now be undertaken with increased urgency, and at an accelerated pace.
I have reached out to donor countries, to UNITAID, to the GAVI Alliance, the World Bank and others to mobilize resources.
I have reached out to companies manufacturing antiviral drugs to assess capacity and all options for ramping up production.
I have also reached out to influenza vaccine manufacturers that can contribute to the production of a pandemic vaccine.
The biggest question, right now, is this: how severe will the pandemic be, especially now at the start?
It is possible that the full clinical spectrum of this disease goes from mild illness to severe disease. We need to continue to monitor the evolution of the situation to get the specific information and data we need to answer this question.
From past experience, we also know that influenza may cause mild disease in affluent countries, but more severe disease, with higher mortality, in developing countries.
No matter what the situation is, the international community should treat this as a window of opportunity to ramp up preparedness and response.
Above all, this is an opportunity for global solidarity as we look for responses and solutions that benefit all countries, all of humanity. After all, it really is all of humanity that is under threat during a pandemic.
As I have said, we do not have all the answers right now, but we will get them.
Thank you.
10:33am UK, Wednesday April 29, 2009
The Department of Health has confirmed it is in talks to increase urgently the stockpile of surgical face masks for health staff to help stop the spread of swine flu.
Picture from SKY.com news
Every household in Britain is to be sent a leaflet about dealing with swine flu
Information leaflets are to be sent to all UK homes to help prevent people from catching the virus, which has so far infected at least two Britons.
The leaflets, which describe the virus and advise people how to deal with it, are to be distributed next week.
The steps come as health professionals prepare for the emergence of more suspected cases of swine flu.
A highly secure laboratory in North London is preparing to receive and test samples of the swine flu virus from the US in a level four category containment lab - the most secure there is for this type of work.
Are govoments doing enough? your comments
The director of the World Influeza Centre, Dr Alan Hay, warned the swine flu epidemic could kill people in the UK and elsewhere in the US and Europe.
He said: "If it does spread like a normal influenza virus it's likely that there will be fatalities.
"But this country is well prepared to tackle the disease and globally the medical community has been expecting a flu pandemic for some time."
Dr Alan Hay
Dr Hay said scientists know what the virus is but it is too late to stop it.
"There was always the hope that if one saw it early enough one might be able to nip it in the bud. It's past that time, it's been spreading," he said.
"It's been a very significant epidemic in Mexico, it's spreading around the world so we can't stop it.
"Fortunately the drug is stockpiled for a large number of the population."
The researchers are hoping to find similarities between swine flu and viruses already found in humans to establish how best to tackle it.
Are govoments doing enough?your comments
1976 Swine flue outbreak
Your feed backs
If you wish to send a feed back, please click here
Latest Pictures
